Cargando…
New-Onset and Relapsed Membranous Nephropathy post SARS-CoV-2 and COVID-19 Vaccination
Since the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak and COVID-19 vaccination, new-onset and relapsed clinical cases of membranous nephropathy (MN) have been reported. However, their clinical characteristics and pathogenesis remained unclear. In this article, we collected...
Autores principales: | Ma, Qiqi, Li, Xiang, Xu, Gaosi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611660/ https://www.ncbi.nlm.nih.gov/pubmed/36298697 http://dx.doi.org/10.3390/v14102143 |
Ejemplares similares
-
New-Onset Acute Interstitial Nephritis Post-SARS-CoV-2 Infection and COVID-19 Vaccination: A Panoramic Review
por: Wang, Yu, et al.
Publicado: (2023) -
Relapse of primary membranous nephropathy after inactivated SARS-CoV-2 virus vaccination
por: Aydın, Mehmet Fethullah, et al.
Publicado: (2021) -
New-onset IgA nephropathy following COVID-19 vaccination
por: Ma, Yaohui, et al.
Publicado: (2022) -
337 Relapse of Membranous Nephropathy and Renal Sarcoidosis Following Exposure to SARS-CoV-2 Vaccine (Johnson & Johnson)
Publicado: (2022) -
SARS-CoV-2 infection and COVID-19 vaccination in cancer patients undergoing immune checkpoint inhibitors
por: Yang, Yang, et al.
Publicado: (2023)